Company Analysis Giant Biogene Holding Co., Ltd.
1. Summary
Advantages
- The stock's return over the last year (41.29%) is higher than the sector average (22.48%).
- The company's current efficiency (ROE=33.37%) is higher than the sector average (ROE=15.29%)
Disadvantages
- Price (55.95 HK$) is higher than fair price (30.16 HK$)
- Dividends (0.7921%) are below the sector average (2.55%).
- Current debt level 0.0835% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Giant Biogene Holding Co., Ltd. | Consumer Staples | Index | |
---|---|---|---|
7 days | 3.3% | -0.2% | -0.1% |
90 days | -4.4% | 8.3% | 12.3% |
1 year | 41.3% | 22.5% | 30% |
2367 vs Sector: Giant Biogene Holding Co., Ltd. has outperformed the "Consumer Staples" sector by 18.81% over the past year.
2367 vs Market: Giant Biogene Holding Co., Ltd. has outperformed the market by 11.28% over the past year.
Stable price: 2367 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 2367 with weekly volatility of 0.794% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (55.95 HK$) is higher than the fair price (30.16 HK$).
Price is higher than fair: The current price (55.95 HK$) is 46.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (24.38) is lower than that of the sector as a whole (45.14).
P/E vs Market: The company's P/E (24.38) is lower than that of the market as a whole (46.98).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.64) is higher than that of the sector as a whole (3.06).
P/BV vs Market: The company's P/BV (6.64) is higher than that of the market as a whole (6.29).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.08) is higher than that of the sector as a whole (2.62).
P/S vs Market: The company's P/S indicator (9.08) is lower than that of the market as a whole (20.36).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.92) is higher than that of the sector as a whole (15.86).
EV/Ebitda vs Market: The company's EV/Ebitda (19.92) is lower than that of the market as a whole (38.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 29.91% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (29.91%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-0.4906%).
5.4. ROE
ROE vs Sector: The company's ROE (33.37%) is higher than that of the sector as a whole (15.29%).
ROE vs Market: The company's ROE (33.37%) is higher than that of the market as a whole (2.62%).
5.5. ROA
ROA vs Sector: The company's ROA (29.41%) is higher than that of the sector as a whole (9.12%).
ROA vs Market: The company's ROA (29.41%) is higher than that of the market as a whole (2.83%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.72%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.7921% is below the average for the sector '2.55%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.7921% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.7921% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (44.05%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription